UBS AM

UBS AM’s ARS Pharmaceuticals SPRY Stock Holding History

UBS AM’s Portfolio SPRY Stock Details SPRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.73M	Buy	464,681 +160,236	+53%	+$1.54M	﹤0.01%	1713
2025 Q4	$3.55M	Sell	304,445 -30,703	-9%	-$299K	﹤0.01%	1633
2025 Q3	$3.37M	Buy	335,148 +9,503	+3%	+$136K	﹤0.01%	1549
2025 Q2	$5.68M	Buy	325,645 +45,805	+16%	+$661K	﹤0.01%	1652
2025 Q1	$3.52M	Buy	279,840 +32,526	+13%	+$391K	﹤0.01%	1737
2024 Q4	$2.61M	Buy	247,314 +12,777	+5%	+$179K	﹤0.01%	1914
2024 Q3	$3.4M	Buy	234,537 +207,456	+766%	+$2.47M	﹤0.01%	1771
2024 Q2	$230K	Buy	27,081 +14,141	+109%	+$125K	﹤0.01%	2748
2024 Q1	$132K	Hold	12,940	–	–	﹤0.01%	2488
2023 Q4	$70.9K	Hold	12,940	–	–	﹤0.01%	2533
2023 Q3	$48.9K	Buy	+12,940	New	+$84.9K	﹤0.01%	2580
2021 Q1	–	Sell	-57,575	Closed	-$2.67M	–	2618
2020 Q4	$2.67M	Buy	+57,575	New	+$1.92M	﹤0.01%	1566

Other funds holding SPRY

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return